176 related articles for article (PubMed ID: 32312912)
21. MicroRNA-23b Plays a Tumor-Suppressive Role in Cutaneous Squamous Cell Carcinoma and Targets Ras-Related Protein RRAS2.
Sun C; Mahapatra KD; Elton J; Li C; Fernando W; Lohcharoenkal W; Lapins J; Homey B; Sonkoly E; Pivarcsi A
J Invest Dermatol; 2023 Dec; 143(12):2386-2396. PubMed ID: 37423552
[TBL] [Abstract][Full Text] [Related]
22. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
23. Identification of genetic mutations of cutaneous squamous cell carcinoma using whole exome sequencing in non-Caucasian population.
Lee SY; Lee M; Yu DS; Lee YB
J Dermatol Sci; 2022 May; 106(2):70-77. PubMed ID: 35365379
[TBL] [Abstract][Full Text] [Related]
24. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
[TBL] [Abstract][Full Text] [Related]
25. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.
Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y
J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056
[TBL] [Abstract][Full Text] [Related]
26. Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity.
Piipponen M; Nissinen L; Farshchian M; Riihilä P; Kivisaari A; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2016 Aug; 136(8):1701-1710. PubMed ID: 27049681
[TBL] [Abstract][Full Text] [Related]
27. Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma.
Sato Y; Fujimura T; Hidaka T; Lyu C; Tanita K; Matsushita S; Yamamoto M; Aiba S
Front Immunol; 2020; 11():534323. PubMed ID: 33178182
[TBL] [Abstract][Full Text] [Related]
28. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
[TBL] [Abstract][Full Text] [Related]
29. WW domain-containing E3 ubiquitin protein ligase 1 depletion evokes antitumor effect in cutaneous squamous cell carcinoma by inhibiting signal transducer and activator of transcription 3 signaling pathway.
Xia Y; Chang X; Lian S; Zhu W
J Int Med Res; 2018 Jul; 46(7):2898-2912. PubMed ID: 29888632
[TBL] [Abstract][Full Text] [Related]
30. Unraveling the interplay between senescent dermal fibroblasts and cutaneous squamous cell carcinoma cell lines at different stages of tumorigenesis.
Toutfaire M; Dumortier E; Fattaccioli A; Van Steenbrugge M; Proby CM; Debacq-Chainiaux F
Int J Biochem Cell Biol; 2018 May; 98():113-126. PubMed ID: 29550586
[TBL] [Abstract][Full Text] [Related]
31. The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and induces tumorigenic properties.
Hoesl C; Zanuttigh E; Fröhlich T; Philippou-Massier J; Krebs S; Blum H; Dahlhoff M
Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118717. PubMed ID: 32283126
[TBL] [Abstract][Full Text] [Related]
32. Collagens XV and XVIII show different expression and localisation in cutaneous squamous cell carcinoma: type XV appears in tumor stroma, while XVIII becomes upregulated in tumor cells and lost from microvessels.
Karppinen SM; Honkanen HK; Heljasvaara R; Riihilä P; Autio-Harmainen H; Sormunen R; Harjunen V; Väisänen MR; Väisänen T; Hurskainen T; Tasanen K; Kähäri VM; Pihlajaniemi T
Exp Dermatol; 2016 May; 25(5):348-54. PubMed ID: 26660139
[TBL] [Abstract][Full Text] [Related]
33. Combined Kdm6a and Trp53 Deficiency Drives the Development of Squamous Cell Skin Cancer in Mice.
Shea LK; Akhave NS; Sutton LA; Compton LA; York C; Ramakrishnan SM; Miller CA; Wartman LD; Chen DY
J Invest Dermatol; 2023 Feb; 143(2):232-241.e6. PubMed ID: 36055401
[TBL] [Abstract][Full Text] [Related]
34. miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells.
Hoareau-Aveilla C; Quelen C; Congras A; Caillet N; Labourdette D; Dozier C; Brousset P; Lamant L; Meggetto F
Haematologica; 2019 Feb; 104(2):347-359. PubMed ID: 30262555
[TBL] [Abstract][Full Text] [Related]
35. Yes-Associated Protein Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma via Activation of RAS.
Jia J; Li C; Luo S; Liu-Smith F; Yang J; Wang X; Wang N; Lai B; Lei T; Wang Q; Xiao S; Shao Y; Zheng Y
J Invest Dermatol; 2016 Jun; 136(6):1267-1277. PubMed ID: 26902922
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.
Corchado-Cobos R; García-Sancha N; González-Sarmiento R; Pérez-Losada J; Cañueto J
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331425
[TBL] [Abstract][Full Text] [Related]
37. Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia.
Vivancos Stalin L; Gualandi M; Schulte JH; Renella R; Shakhova O; Mühlethaler-Mottet A
Front Oncol; 2019; 9():275. PubMed ID: 31058082
[TBL] [Abstract][Full Text] [Related]
38. Loss of TGF-β signaling drives cSCC from skin stem cells - More evidence.
Rose AM; Sansom OJ; Inman GJ
Cell Cycle; 2017 Mar; 16(5):386-387. PubMed ID: 27860538
[No Abstract] [Full Text] [Related]
39. Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways.
Chen H; Pan J; Zhang L; Chen L; Qi H; Zhong M; Shi X; Du J; Li Q
Eur J Pharmacol; 2018 Apr; 825():133-142. PubMed ID: 29476880
[TBL] [Abstract][Full Text] [Related]
40. Genomic analysis of metastatic cutaneous squamous cell carcinoma.
Li YY; Hanna GJ; Laga AC; Haddad RI; Lorch JH; Hammerman PS
Clin Cancer Res; 2015 Mar; 21(6):1447-56. PubMed ID: 25589618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
